Drug General Information
Drug ID
D0V9QR
Former ID
DNC000244
Drug Name
Apricitabine
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 3 [522332]
Structure
Download
2D MOL

3D MOL

Formula
C8H11N3O3S
Canonical SMILES
C1C(SC(O1)CO)N2C=CC(=NC2=O)N
InChI
1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m1/s1
InChIKey
RYMCFYKJDVMSIR-RNFRBKRXSA-N
CAS Number
CAS 160707-69-7
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 522332ClinicalTrials.gov (NCT00686270) A Long Term Safety Study of Apricitabine in HIV-infected Patients. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.